A first analysis was performed to determine whether NMO-IgG from AQP4-positive NMOSD patients may orchestrate BBB alteration by inducing a specific cytokine secretome profile in isolated brain microvessels (IBMs). This evidence concerns the gene AQP4 and neuromyelitis optica.